158 related articles for article (PubMed ID: 28236913)
1. A modest proposal.
Patterson RB
J Vasc Surg; 2017 Mar; 65(3):594-602. PubMed ID: 28236913
[No Abstract] [Full Text] [Related]
2. A systematic review of treatment of intermittent claudication in the lower extremities.
Malgor RD; Alahdab F; Elraiyah TA; Rizvi AZ; Lane MA; Prokop LJ; Phung OJ; Farah W; Montori VM; Conte MS; Murad MH
J Vasc Surg; 2015 Mar; 61(3 Suppl):54S-73S. PubMed ID: 25721067
[TBL] [Abstract][Full Text] [Related]
3. Structured Home-Based Exercise Versus Invasive Treatment: A Mission Impossible? A Pilot Randomized Study in Elderly Patients With Intermittent Claudication.
Lamberti N; Malagoni AM; Ficarra V; Basaglia N; Manfredini R; Zamboni P; Mascoli F; Manfredini F
Angiology; 2016 Sep; 67(8):772-80. PubMed ID: 26635335
[TBL] [Abstract][Full Text] [Related]
4. Part two: against the motion. endovascular therapy is the preferred treatment for patients <65 years old with symptomatic infrainguinal arterial disease.
Houbballah R; Raux M; LaMuraglia G
Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):116-9. PubMed ID: 22878046
[No Abstract] [Full Text] [Related]
5. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
[TBL] [Abstract][Full Text] [Related]
7. Improved Adherence to a Stepped-care Model Reduces Costs of Intermittent Claudication Treatment in The Netherlands.
Hageman D; Fokkenrood HJP; Essers PPM; Koelemay MJW; Breek JC; Vahl AC; Scheltinga MRM; Teijink JAW
Eur J Vasc Endovasc Surg; 2017 Jul; 54(1):51-57. PubMed ID: 28539212
[TBL] [Abstract][Full Text] [Related]
8. Understanding Patient Acceptance of Risk with Treatment Options for Intermittent Claudication.
Morbi AHM; Coles S; Albayati M; Nordon IM; Shearman C
Ann Vasc Surg; 2017 Apr; 40():223-230. PubMed ID: 27908805
[TBL] [Abstract][Full Text] [Related]
9. Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials.
Pandey A; Banerjee S; Ngo C; Mody P; Marso SP; Brilakis ES; Armstrong EJ; Giri J; Bonaca MP; Pradhan A; Bavry AA; Kumbhani DJ
JACC Cardiovasc Interv; 2017 Apr; 10(7):712-724. PubMed ID: 28385410
[TBL] [Abstract][Full Text] [Related]
10. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
[TBL] [Abstract][Full Text] [Related]
12. Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).
Pokharel Y; Jones PG; Graham G; Collins T; Regensteiner JG; Murphy TP; Cohen D; Spertus JA; Smolderen K
Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004157. PubMed ID: 29643064
[No Abstract] [Full Text] [Related]
13. Editor's Choice - Cost Effectiveness of Primary Stenting in the Superficial Femoral Artery for Intermittent Claudication: Two Year Results of a Randomised Multicentre Trial.
Djerf H; Svensson M; Nordanstig J; Gottsäter A; Falkenberg M; Lindgren H
Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):576-582. PubMed ID: 34454817
[TBL] [Abstract][Full Text] [Related]
14. Integrative therapy in patients with intermittent claudication.
Minar E
Vasa; 2015 Mar; 44(2):85-91. PubMed ID: 25698386
[TBL] [Abstract][Full Text] [Related]
15. Exercise training for intermittent claudication.
McDermott MM
J Vasc Surg; 2017 Nov; 66(5):1612-1620. PubMed ID: 28874320
[TBL] [Abstract][Full Text] [Related]
16. Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.
Madabhushi V; Davenport D; Jones S; Khoudoud SA; Orr N; Minion D; Endean E; Tyagi S
J Vasc Surg; 2021 Sep; 74(3):771-779. PubMed ID: 33775749
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of infrainguinal arterial occlusive disease.
Pennywell DJ; Tan TW; Zhang WW
Vasc Health Risk Manag; 2014; 10():599-608. PubMed ID: 25368519
[TBL] [Abstract][Full Text] [Related]
18. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association.
Treat-Jacobson D; McDermott MM; Bronas UG; Campia U; Collins TC; Criqui MH; Gardner AW; Hiatt WR; Regensteiner JG; Rich K;
Circulation; 2019 Jan; 139(4):e10-e33. PubMed ID: 30586765
[No Abstract] [Full Text] [Related]
19. Variations in the Management of Claudication in a Tertiary Care Center.
Ochoa Chaar CI; Gholitabar N; Detrani M; Jorshery SD; Kim TI; Zhuo H; Zhang Y; Dardik A
Ann Vasc Surg; 2020 Aug; 67():395-402. PubMed ID: 32179142
[TBL] [Abstract][Full Text] [Related]
20. Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management.
Bouwens E; Klaphake S; Weststrate KJ; Teijink JA; Verhagen HJ; Hoeks SE; Rouwet EV
Vasc Med; 2019 Jun; 24(3):208-215. PubMed ID: 30795714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
